The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
Fatal drug overdoses quadrupled from 1999 to 2020
Sep 19, 2023
The highest rate increases were seen in white and Native American or Alaskan Native individuals and in the Midwest and nonmetro areas.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.